Hebei Changshan Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HEBEI CHANGSHAN
HEBEI CHANGSHAN has one approved drug.
Drugs and US Patents for Hebei Changshan
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hebei Changshan | ENOXAPARIN SODIUM (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 218775-003 | Jan 7, 2026 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hebei Changshan | ENOXAPARIN SODIUM (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 218775-002 | Jan 7, 2026 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hebei Changshan | ENOXAPARIN SODIUM (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 218775-005 | Jan 7, 2026 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hebei Changshan | ENOXAPARIN SODIUM (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 218775-004 | Jan 7, 2026 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hebei Changshan | ENOXAPARIN SODIUM (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 218775-007 | Jan 7, 2026 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

